World Journal of Dentistry

Register      Login

VOLUME 9 , ISSUE 3 ( May-June, 2018 ) > List of Articles

REVIEW ARTICLE

Recent Advancements in Oral Lichen Planus Management: An Overview

Karthikeya Patil, Athira Joshy, Nagabushana Doggalli, Jai Shankar, Chikkarasinakere J Gowda, Prasannasrinivas Deshpande

Keywords : Aloe vera, Green tea, Oral lichen planus, Propolis, Recent advances

Citation Information : Patil K, Joshy A, Doggalli N, Shankar J, Gowda CJ, Deshpande P. Recent Advancements in Oral Lichen Planus Management: An Overview. World J Dent 2018; 9 (3):249-251.

DOI: 10.5005/jp-journals-10015-1542

License: CC BY-SA 4.0

Published Online: 00-06-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Lichen planus is a chronic inflammatory, autoimmune, mucocutaneous disease of which the etiology is unknown. In Greek “lichen” means tree moss and “planus” means flat. It affects the skin, mucous membrane, nails, and hair. It is seen in 1 to 2% of the population. As the exact causative factor for oral lichen planus (OLP) is a matter of conflict, the failure to achieve proper or specific treatment for it may be reason for its incomplete regression. Corticosteroids are the mainstay of OLP but because of their adverse effects various other agents have been tried in the treatment of OLP. Aim: The aim of this review is to provide an update on the recent advances in the treatment of OLP. Results: An electronic search was conducted across Medline, Cochrane, Web of Science databases, and Google Scholar for the purpose of literature analysis on the mentioned topic. The studies were reviewed and compared. This article summarizes the recent advances in the treatment of OLP. Conclusion: Oral lichen planus has been an advanced researched oral potentially malignant disorder over the years. The newer treatment modalities have been considered to be beneficial with lesser amount of side effects than corticosteroids like amlexanox (AX), aloe vera gel, green tea, curcumin, propolis, and lycopene. Clinical significance: Oral lichen planus is seen in 1 to 2% of the population who come with varied symptoms or may be asymptomatic. Although treatment options are plenty, the mainstay of treatment is corticosteroids. However, the use of alternate therapeutics is proven to be effective with lesser side effects.


PDF Share
  1. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 2010 Jan-Feb;28(1):100-108.
  2. Patil S, Rao RS, Sanketh DS, Sarode SC, Sarode GS. A universal diagnostic criteria for oral lichen planus: an exigency!. Int J Contemp Dent Med Rev 2014;2014:041214.
  3. Greenberg MS, Glick M, Ship JA. Burket's oral medicine. 11th ed. Hamilton: BC Decker; 2008.
  4. Shadab S, Sodhi SJ, Patil SP, Tambe SD, Kasat R. Management of oral lichen planus: overview. Pravara Med Rev 2016;8(1).
  5. Javadzadeha A, Vatanpourb H, Delavariana Z, Momajed A, Esmaeily H, Vatanpour M, Shirazian S. Efficacy of clobetasol, ketoconazole and amitriptyline mouthwash on oral lichen planus. Iranian J Pharm Res 2008;7(3):171-178.
  6. Fu J, Zhu X, Dan H, Zhou Y, Liu C, Wang F, Li Y, Liu N, Chen Q, Xu Y, et al. Amlexanox is as effective as dexamethasone in topical treatment of erosive oral lichen planus: a short-term pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012 May;113(5):638-643.
  7. Chainani-Wu N, Madden E, Lozada-Nur F, Silverman S Jr. High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol 2012 May;66(5):752-760.
  8. Elshenawy HM, Eldin AM, Abdelmonem MA (2015) Clinical assessment of the efficiency of low level laser therapy in the treatment of oral lichen planus. Open Access Maced J Med Sci 3(4):717-721.
  9. Eduardo Fde P, Bueno DF, de Freitas PM, Marques MM, Passos-Bueno MR, Eduardo Cde P, Zatz M. Stem cell proliferation under low intensity laser irradiation: a preliminary study. Lasers Surg Med 2008 Aug;40(6):433-438.
  10. Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad-Moghadam S, Karagah A. Efficacy of purslane in the treatment of oral lichen planus. Phytother Res 2010 Feb;24(2):240-244.
  11. Franks ME, Macpherson GR. Thalidomide. Lancet 2004 May 29;363(9423):1802-1811.
  12. Matthews SJ, McCoy C. Thalidomide: a review of approved and investigated uses. Clin Ther 2003 Feb;25(2):342-395.
  13. Wu Y, Zhou G, Zeng H, Xiong CR, Lin M, Zhou HM. A randomized double-blind positive control trial of topical thalidomide in erosive oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Aug;110(2):188-195.
  14. Levy J, Sharoni Y. The functions of tomato lycopene and its role in human health. Herbalgram 2004;62:4956.
  15. Stahl W, Sies H. Lycopene: A biologically important carotenoid for humans? Arch Biochem Biophys 1996 Dec;336(1):1-9.
  16. Saawarn N, Shashikanth MC, Saawarn S, Jirge V, Chaitanya NC, Pinakapani R. Lycopene in the management of oral lichen planus: a placebo-controlled study. Indian J Dent Res 2011 Sep-Oct;22(5):639-643.
  17. Shelton RM. Aloe vera; its chemical and therapeutic properties. Int J Dermatol 1991 Oct;30(10):679-683.
  18. Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999 Oct;49(447):823-828.
  19. Yagi A, Kabash A, Okamura N, Haraguchi H, Moustafa SM, Khalifa TI. Antioxidant, free radical scavenging and antiinflammatory effects of aloesin derivatives in aloe vera. Planta Med 2002 Nov;68(11):957-960.
  20. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P. The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol 2008 Mar;158(3):573-577.
  21. Ialenti A, Di Rosa M. Hyaluronic acid modulates acute and chronic inflammation. Agents Actions 1994;43:44-47.
  22. Nolan A, Badminton J, Maguire J, Seymour RA. The efficacy of topical hyaluronic acid in the management of oral lichen planus. J Oral Pathol Med 2009 Mar;38(3):299-303.
  23. Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea—a review. J Am Coll Nutr 2006;25:79-99.
  24. Yoneyama S, Kawai K, Tsuno NH, Okaji Y, Asakage M, Tsuchiya T, Yamada J, Sunami E, Osada T, Kitayama J, et al. Epigallocatechingallate affects human dendritic cell differentiation and maturation. J Allergy Clin Immunol 2008 Jan;121(1):209-214.
  25. Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakage M, Sasaki S, Watanabe T, Takahashi K, Nagawa H. Epigallocatechin gallate induces apoptosis of monocytes. J Allergy Clin Immunol 2005 Jan;115(1):186-191.
  26. Zhang J, Zhou G. Green tea consumption: an alternative approach to managing oral lichen planus. Inflamm Res 2012 Jun;61(6):535-539.
  27. Marzotto M, Conforti A, Magnani P, Zanolin ME, Bellavite P. Effects of Ignatia amara in mouse behavioural models. Homeopathy 2012 Jan;101(1):57-67.
  28. Mousavi F, Sherafati S, Mojaver YN. Ignatia in the treatment of oral lichen planus. Homeopathy 2009 Jan;98(1):40-44.
  29. Zyada MM, El-Said Elewa M, El-Meadawy S, El Sharkawy H. Effectiveness of topical mucoadhesive gel containing propolis in management of patients with atrophic and erosive oral lichen planus: clinical and immunohistochemical study. Egypt Dent Assoc 2012;58:1-3.
  30. Kainz J, Braun H, Genser P. Haller's cells: morphologic evaluation and clinico-surgical relevance. Laryngorhinootologie 1993 Dec;72(12):599-604.
  31. Ahmad M, Khurana N, Jaberi J, Sampair C, Kuba RK. Prevalence of infraorbital ethmoid (Haller's) cells on panoramic radiographs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 May;101(5):658-661.
  32. Khojastepour L, Mirhadi S, Mesbahi SA. Anatomical variations of ostiomeatal complex in CBCT of patients seeking rhinoplasty. J Dent 2015 Mar;16(1):42-48.
  33. Raina A, Guledgud MV, Patil K. Infraorbital ethmoid (Haller's) cells: a panoramic radiographic study. Dentomaxillofac Radiol 2012 May;41(4):305-308.
  34. Kamdi P, Nimma V, Gogri A. Role of CBCT in Haller cells identification and its clinical significance. Int J Curr Res 2017 Jun;9(06):52630-52635.
  35. Fadda G, Rosso S, Aversa S, Ondolo C, Succo G. Multiparametric statistical correlations between paranasal sinus anatomic variations and chronic rhinosinusitis. Acta Otorhinolaryngol Ital 2012 Aug;32(4):244-251.
  36. Khayam E, Mahabadi AM, Ezoddini F, Mohamad AG, Zeinab H, Malihe M, Razavi SH. The prevalence of ethmoidal infraorbital cells in panoramic radiography. Am J Res Commun 2013;1(2):109-118.
  37. Göçmen G, Borahan MO, Aktop S, Dumlu A, Pekiner FN, Göker K. Effect of septal deviation, concha bullosa and Haller's cell on maxillary sinus's inferior pneumatization: a retrospective study. Open Dent J 2015 Jul 31;9:282-286.
  38. Pekiner FN, Borahan MO, Dumlu A, Ozbayrak S. Infraorbital ethmoid (Haller) cells: a cone-beam computed tomographic study. Oral Radiol 2014;30(3):219-225.
  39. Sebrechts H, Vlaminck S, Casselman J. Orbital edema resulting from Haller cell pathology: 3 case reports and review of literature. Acta Otorhinolaryngol Belg 2000;54(1):39-43.
  40. Cook PR, Nishioka GJ, Davis WE, McKinsey JP. Functional endoscopic sinus surgery in patients with normal computed tomography scans. Otolaryngol Neck Surg 1994 Jun; 110(6):505-509.
  41. Choi JH. Hypoesthesia of midface by isolated Haller's cell mucocele. Braz J Otorhinolaryngol 2016 Jul 22. pii:S1808- 8694(16)30138-0.
  42. Salonen MA, Oikarinen K, Virtanen K, Pernu H. Failures in the osseointegration of endosseous implants. Int J Oral Maxillofac Implants 1993;8(1):92-97.
  43. Zhang X, Sun Z, Yang Q. Application of Denaturing gradient gel electrophoresis to the analysis of bacterial communities associated with asymptomatic and symptomatic pericoronitis. J Oral Maxillofac Surg 2018 Mar;76(3):483-489.
  44. Suárez-López Del Amo F, Yu SH, Wang HL. Non-surgical therapy for peri-implant diseases: a systematic review. J Oral Maxillofac Res 2016 Sep;7(3):e13.
  45. Aberg CH, Kelk P, Johansson A. Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitis. Virulence 2015 Apr;6(3):188-195.
  46. Larsen OI, Enersen M, Kristoffersen AK, Wennerberg A, Bunæs DF, Lie SA, Leknes KN. Antimicrobial effects of three different treatment modalities on dental implant surfaces. J Oral Implantol 2017 Dec;43(6):429-436.
  47. Prathapachandran J, Suresh N. Management of periimplantitis. Dent Res J (Isfahan) 2012 Sep-Oct;9(5):516-521.
  48. Bhattacharyya M, Kumar AN, Kapuria S. Synthesis and characterization of Al/SiC and Ni/Al2O3 functionally graded materials. Mater Sci Eng A 2008 Jul;487(1-2):524-535.
  49. Chenglin C, Jingchuan Z, Zhongda Y, Shidong W. Hydroxyapatite-Ti functionally graded biomaterial fabricated by powder metallurgy. Mater Sci Eng A 1999 Nov;271(1):95-100.
  50. Oleiwi JK, Anaee RA, Muhsin SA. Fabrication, characterization and physical properties of functionally graded Ti/HAP bioimplants. Wulfenia J 2015 Jul;22(7):336-348.
  51. Ogawa T, Watanabe Y, Sato H, Kim IS, Fukui Y. Theoretical study on fabrication of functionally graded material with density gradient by a centrifugal solid-particle method. Compos Part A Appl S 2006 Dec;37(12):2194-2200.
  52. Yang ZM, Tian F, Zhang LM. Theoretical study on two sedimentation processes used to form functionally graded materials. J Mater Sci Lett 2003 May;22(10):739-741.
  53. Yang ZM, Gong DR, Zhang LM. Design of co-sedimentation experiments used to fabricate functionally graded materials with a continuous change of composition. J Wuhan Univ Technol Mater Sci Ed 2004 Jan;19(2):11-13.
  54. Jin G, Takeuchi M, Honda S, Nishikawa T, Awaji H. Properties of multilayered mullite/Mo functionally graded materials fabricated by powder metallurgy processing. Mater Chem Physics 2005 Feb;89(2):238-243.
  55. Jamaludin SN, Basri S, Hussain A, Al-Othmany DS, Mustapha F, Nuruzzaman DM. Three-dimensional finite element modeling of thermomechanical problems in functionally graded hydroxyapatite/titanium plate. Math Probl Eng 2014 Apr;2014:371462.
  56. Halpern LR, Dodson TB. Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory complications after third molar surgery? J Oral Maxillofac Surg 2007 Feb;65(2):177-185.
  57. Lopez-Cedrun JL, Pijoan JI, Fernandez S, Santamaria J, Hernandez G. Efficacy of amoxycillin treatment in preventing postoperative complications in patients undergoing third molar surgery: a prospective, randomized, double-blind controlled study. J Oral Maxillofac Surg 2011 Jun;69(6):e5-e14.
  58. Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2016 Jul;21(4):e494-e504.
  59. Piltz JR, Starita RJ. The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy. Ophthalmic Surg 1994 Jan;25(1):51-53.
  60. Por YM, Tan YL, Mehta JS, Tan DT. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations. Cornea 2009 May;28(4):451-455.
  61. Sakarya Y, Sakarya R, Yildirim A. Sutureless amniotic membrane fixation with fibrin glue in symptomatic bullous keratopathy with poor visual potential. Eur J Ophthalmol 2010 Jan-Feb;20(1):249; author reply 249-250.
  62. Lee GA, Holcombe DJ. Surgical revision of dysfunctional filtration blebs with bleb preservation sliding conjunctival flap and fibrin glue. Eye (Lond) 2010 Jun;24(6):947-953.
  63. Kahook MY, Noecker RJ. Fibrin glue-assisted glaucoma drainage device surgery. Br J Ophthalmol 2006 Dec;90(12):1486-1489.
  64. Valimaki J. Fibrin glue for preventing immediate postoperative hypotony following glaucoma drainage implant surgery. Acta Ophthalmol Scand 2006 Jun;84(3):372-374.
  65. Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant 2014 Jun;4(2):111-121.
  66. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004 Jan-Feb;49(1):51-77.
  67. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001 May;20(4):408-413.
  68. Yazdani S, Mahboobipour H, Pakravan M, Doozandeh A, Ghahari E. Adjunctive mitomycin c or amniotic membrane transplantation for Ahmed glaucoma valve implantation: a randomized clinical trial. J Glaucoma 2016 May;25(5):415-421.
  69. Sheha H, Kheirkhah A, Taha H. Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma. J Glaucoma 2008 Jun-Jul;17(4):303-307.
  70. Khairy HA, Elsawy MF. Trabeculectomy with mitomycin-C versus trabeculectomy with amniotic membrane transplant: a medium-term randomized controlled trial. J Glaucoma 2015 Sep;24(7):556-559.
  71. Rauscher FM, Barton K, Budenz DL, Feuer WJ, Tseng SC. Long-term outcomes of amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am J Ophthalmol 2007 Jun;143(6):1052-1054.
  72. Sethi P, Patel RN, Goldhardt R, Ayyala RS. Conjunctival advancement with subconjunctival amniotic membrane draping technique for leaking cystic blebs. J Glaucoma 2016 Feb;25(2):188-192.
  73. Kitagawa K, Yanagisawa S, Watanabe K, Yunoki T, Hayashi A, Okabe M, Nikaido T. A hyperdry amniotic membrane patch using a tissue adhesive for corneal perforations and bleb leaks. Am J Ophthalmol 2009 Sep;148(3):383-389.
  74. Nagai-Kusuhara A, Nakamura M, Fujioka M, Negi A. Longterm results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. Graefes Arch Clin Exp Ophthalmol 2008 Apr;246(4):567-571.
  75. Rai P, Lauande-Pimentel R, Barton K. Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices. Am J Ophthalmol 2005 Dec;140(6): 1148-1152.
  76. Ainsworth G, Rotchford A, Dua HS, King AJ. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br J Ophthalmol 2006 Apr;90(4):417-419.
  77. Papadaki TG, Siganos CS, Zacharopoulos IP, Panteleontidis V, Charissis SK. Human amniotic membrane transplantation for tube exposure after glaucoma drainage device implantation. J Glaucoma 2007 Jan;16(1):171-172.
  78. Mulder EJ, Leiblum DM, Visser GH. Fetal breathing movements in late diabetic pregnancy: relationship to fetal heart rate patterns and Braxton Hicks’ contractions. Early Hum Dev 1995 Nov;43(3):225-232.
  79. Schulte FJ, Michaelis R, Nolte R, Albert G, Parl U, Lasson U. Brain and behavioral maturation in newborn infants of diabetic mothers. I. Nerve conduction and EEG patterns. Neuropadiatrie 1969 Jan-Jul;1(1):24-35.
  80. Devoe LD, Youssef AA, Castillo RA, Croom CS. Fetal biophysical activities in third-trimester pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1994 Aug;171(2):298-303.
  81. Dierker LJ Jr, Pillay S, Sorokin Y, Rosen MG. The change in fetal activity periods in diabetic and nondiabetic pregnancies. Am J Obstet Gynecol 1982 May;143(2):181-185.
  82. Doherty NN, Hepper PG. Habituation in fetuses of diabetic mothers. Early Hum Dev 2000 Aug;59(2):85-93.
  83. Kainer F, Prechtl HF, Engele H, Einspieler C. Assessment of the quality of general movements in fetuses and infants of women with type-1 diabetes mellitus. Early Hum Dev 1997 Nov;50(1):13-25.
  84. Mulder EJ, O'Brien MJ, Lems YL, Visser GH, Prechtl HF. Body and breathing movements in near-term fetuses and newborn infants of type-1 diabetic women. Early Hum Dev 1990 Nov;24(2):131-152.
  85. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. I. Early growth patterns. Early Hum Dev 1991 May;25(2):91-106.
  86. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. II. Emergence of specific movement patterns. Early Hum Dev 1991 May;25(2):107-115.
  87. Mulder EJ, Visser GH. Impact of early growth delay on subsequent fetal growth and functional development: a study on diabetic pregnancy. Early Hum Dev 1992 Dec;31(2):91-95.
  88. Mulder EJ, Visser GH, Bekedam DJ, Prechtl HF. Emergence of behavioral states in fetuses of type-1 diabetic women. Early Hum Dev 1987 Jul;15(4):231-251.
  89. Mulder EJ, Visser GH, Morssink LP, de Vries JI. Growth and motor development in fetuses of women with type-1 diabetes. III. First trimester quantity of fetal movement patterns. Early Hum Dev 1991 May;25(2):117-133.
  90. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001 Mar;61(2):85-95.
  91. Deregnier RA, Nelson CA, Thomas KM, Wewerka S, Georgieff MK. Neurophysiologic evaluation of auditory recognition memory in healthy newborn infants and infants of diabetic mothers. J Pediatr 2000 Dec;137(6):777-784.
  92. Nelson CA, Wewerka S, Thomas KM, Tribby-Walbridge S, deRegnier R, Georgieff M. Neurocognitive sequelae of infants of diabetic mothers. Behav Neurosci 2000 Oct;114(5):950-956.
  93. Reece EA, Homko CJ. Infant of the diabetic mother. Semin Perinatol 1994 Oct;18(5):459-469.
  94. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 2000 Mar;43(1):32-45.
  95. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 1991 Sep;325(13):911-916.
  96. Rizzo TA, Metzger BE, Dooley SL, Cho NH. Early malnutrition and child neurobehavioral development: insights from the study of children of diabetic mothers. Child Dev 1997 Feb;68(1):26-38.
  97. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000 Apr;24(2):120-135.
  98. Vaarasmaki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000 Jul;59(1):61-70.
  99. Robertson SS, Dierker LJ. Fetal cyclic motor activity in diabetic pregnancies: sensitivity to maternal blood glucose. Dev Psychobiol 2003 Jan;42(1):9-16.
  100. Accardo PJ, Blondis TA, Whitman BY. Disorders of attention and activity level in a referral population. Pediatrics 1990 Mar;85(3 Pt 2):426-431.
  101. Ornoy A, Uriel L, Tennenbaum A. Inattention, hyperactivity and speech delay at 2-4 years of age as a predictor for ADDADHD syndrome. Isr J Psychiatry Relat Sci 1993;30(3):155-163.
  102. Smyth TR. Impaired motor skill (clumsiness) in otherwise normal children: a review. Child Care Health Dev 1992 Sep-Oct;18(5):283-300.
  103. Petersen MB, Pedersen SA, Greisen G, Pedersen JF, Mølsted- Pedersen L. Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J (Clin Res Ed) 1988 Feb;296(6622):598-600.
  104. Sells CJ, Robinson NM, Brown Z, Knopp RH. Long-term developmental follow-up of infants of diabetic mothers. J Pediatr 1994 Jul;125(1):S9-S17.
  105. Vladareanu R, Lebit D, Constantinescu S. Ultrasound assessment of fetal neurobehaviour in high risk pregnancies. DSJUOG 2012 Apr-Jun;6(2):132-147.
  106. Talic A, Kurjak A, Ahmed B, Stanojevic M, Predojevic M, Kadic AS, Di Renzo GC. The potential of 4D sonography in the assessment of fetal behavior in high-risk pregnancies. J Matern Fetal Neonatal Med 2011 Jul;24(7):948-954.
  107. Bekedam DJ, Visser GH, de Vries JJ, Prechtl HF. Motor behaviour in the growth retarded fetus. Early Hum Dev 1985 Nov;12(2):155-165.
  108. Cioni G, Prechtl HF. Preterm and early postterm motor behaviour in low-risk premature infants. Early Hum Dev 1990 Sep;23(3):159-191.
  109. Seme-Ciglenecki P. Predictive value of assessment of general movements for neurological development of highrisk preterm infants: comparative study. Croat Med J 2003 Dec;44(6):721-727.
  110. Abo-Yaqoub S, Kurjak A, Mohammed AB, Shadad A, Abdel-Maaboud M. The role of 4-D ultrasonography in prenatal assessment of fetal neurobehaviour and prediction of neurological outcome. J Matern Fetal Neonatal Med 2012 Mar;25(3):231-236.
  111. Athanasiadis AP, Mikos T, Tambakoudis GP, Theodoridis TD, Papastergiou M, Assimakopoulos E, Tarlatzis BC. Neurodevelopmental fetal assessment using KANET scoring system in low and high-risk pregnancies. J Matern Fetal Neonatal Med 2013 Mar;26(4):363-368.
  112. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012 Jan;97(1):28-38.e25
  113. Sirmans SM, Pate KA. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin Epidemiol 2014; 6:1-13.
  114. Fauser BC, Diedrich K, Bouchard P, Domínguez F, Matzuk M, Franks S, Hamamah S, Simón C, Devroey P, Ezcurra D, et al. Contemporary genetic technologies and female reproduction. Human Reproduction Update 2011 Nov;17(6):829-847.
  115. Balen A, Conway G, Kaltsas G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995 Aug;10(8):2107-2111.
  116. Azziz R, Sanchez L, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004 Feb;89(2):453-462.
  117. Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at longterm follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000 May;52(5):595-600.
  118. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007 Jun;87(6): 1369-1376.
  119. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Givens JHF, Merriman G, editors. The polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific; 1992. p. 377-384.
  120. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 Jan;81(1):19-25.
  121. Azziz R, Carmina E, DeWailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 Nov;91(11):4237-4245.
  122. Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013 May;28(5):1361-1368.
  123. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011 Feb;3:25-35.
  124. ACOG Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No 108: Polycystic ovary syndrome. Obstet Gynecol 2009 Oct;114(4):936-949.
  125. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008 Mar;89(3): 505-522.
  126. Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 2013 Jul;373(1-2):77-82.
  127. Berridge DL, Winter TC. Saline infusion sonohysterography: technique, indications, and imaging findings. J Ultrasound Med 2004 Jan;23(1):97-112.
  128. Allison SJ, Horrow MM, Kim HY, Lev-Toaff AS. Salineinfused sonohysterography: tips for achieving greater success. Radiographics 2011 Nov-Dec;31(7):1991-2004.
  129. O'Neill MJ. Sonohysterography. Radiol Clin North Am 2003 Jul;41(4):781-797.
  130. Bonnamy L, Marret H, Perrotin F, Body G, Berger C, Lansac J. Sonohysterography: a prospective survey of results and complications in 81 patients. Eur J Obstet Gynecol Reprod Biol 2002 Apr;102(1):42-47.
  131. Lindheim SR, Adsuar N, Kushner DM, Pritts EA, Olive DL. Sonohysterography: a valuable tool in evaluating the female pelvis. Obstet Gynecol Surv 2003 Nov;58(11):770-784.
  132. Lindheim SR, Sprague C, Winter TC. Hysterosalpingography and sonohysterography: lessons in technique. AJR Am J Roentgenol 2006 Jan;186(1):24-29.
  133. Jeanty P, Besnard S, Arnold A, Turner C, Crum P. Air-contrast sonohysterography as a first step assessment of tubal patency. J Ultrasound Med 2000 Aug;19(8):519-527.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.